Publications

Post-tuberculosis mortality and morbidity: valuing the hidden epidemic.

QUAIFE, M; HOUBEN, RM G J; Allwood, B; Cohen, T; Coussens, AK; Harries, AD; Van Kampen, S; Marx, FM; SWEENEY, S; Wallis, RS; Menzies, NA;

2020

The Lancet Respiratory Medicine, (2020).8 4 10.1016/S2213-2600(20)30039-4.

Obstetric fistula in southern Mozambique: a qualitative study on women's experiences of care pregnancy, delivery and post-partum.

Boene, H; Mocumbi, S; Högberg, U; HANSON, C; Valá, A; Bergström, A; Sevene, E; Munguambe, K;

2020

REPRODUCTIVE HEALTH, (2020).17 1 10.1186/s12978-020-0860-0.

Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda.

MEDVEDEV, MM; TUMUKUNDE, V; Mambule, I; TANN, CJ; Waiswa, P; CANTER, RR; HANSEN, CH; Ekirapa-Kiracho, E; KATUMBA, K; PITT, C; GRECO, G; BROTHERTON, H; ELBOURNE, D; SEELEY, J; NYIRENDA, M; ALLEN, E; LAWN, JE;

2020

Trials, (2020).21 1 10.1186/s13063-019-4044-6.

Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.

O'BOYLE, S; Bruxvoort, KJ; Ansah, EK; BURCHETT, HE D; CHANDLER, CI R; CLARKE, SE; GOODMAN, C; Mbacham, W; Mbonye, AK; Onwujekwe, OE; STAEDKE, SG; WISEMAN, VL; Whitty, CJ M; HOPKINS, H;

2020

BMC medicine, (2020).18 1 10.1186/s12916-019-1483-6.

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys.

Isaranuwatchai, W; Teerawattananon, Y; Archer, RA; Luz, A; Sharma, M; Rattanavipapong, W; Anothaisintawee, T; Bacon, RL; Bhatia, T; Bump, J; Chalkidou, K; Elshaug, AG; Kim, DD; Reddiar, SK; NAKAMURA, R; Neumann, PJ; Shichijo, A; Smith, PC; Culyer, AJ;

2020

BMJ (Clinical research ed.), (2020).368, 10.1136/bmj.m141.

Is the rise of crowdfunding for medical expenses in the United Kingdom symptomatic of systemic gaps in health and social care?.

Coutrot, IP; Smith, R; CORNELSEN, L;

2020

JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, (2020).25 3 10.1177/1355819619897949.

HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?.

Seo, MK; Straume, O; Akslen, LA; CAIRNS, J;

2020

PharmacoEconomics - Open, (2020).4 3 10.1007/s41669-019-00193-8.

Using research networks to generate trustworthy qualitative public health research findings from multiple contexts.

Nyirenda, L; KUMAR, MB; Theobald, S; Sarker, M; Simwinga, M; Kumwenda, M; JOHNSON, C; Hatzold, K; CORBETT, EL; Sibanda, E; Taegtmeyer, M;